{
  "company": {
    "name": "Citryll",
    "website": "https://citryll.com/",
    "record": "https://startuphistory.org/c/citryll.com"
  },
  "status": null,
  "history_since": "2016-10-08T03:56:11.000Z",
  "baseline": {
    "snapshot_id": "24ca92ad3c9b7bed11af6ad9e136d2cc7ad651e958c350c462cc57089381f2ed",
    "observed_at": "2016-10-08T03:56:11.000Z",
    "headline": "Therapeutic Innovation: targeting neutrophil extracellular traps",
    "description": "Citryll, spun out from ModiQuest is taking a new approach to treat autoimmune diseases like Rheumatoid Arthritis (RA), Colitis and others by extinguishing the source of auto-antigens and neutrophil ex",
    "evidence": "https://web.archive.org/web/20161008035611/http://citryll.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T12:40:54.279Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2019-07-21T11:15:20.000Z",
      "variants": [
        {
          "headline": "Therapeutic Innovation: targeting neutrophil extracellular traps",
          "subhead": "Citryll, spun out from ModiQuest is taking a new approach to treat autoimmune diseases like Rheumatoid Arthritis (RA), Colitis and others by extinguishing the source of auto-antigens and neutrophil ex",
          "observed_at": "2016-10-08T03:56:11.000Z",
          "evidence": "https://web.archive.org/web/20161008035611/http://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Therapeutic Innovation: targeting neutrophil extracellular traps",
          "subhead": "Citryll, spun out from ModiQuest is taking a new approach to treat autoimmune diseases like Rheumatoid Arthritis (RA), Colitis and others by extinguishing the source of auto-antigens and neutrophil ex",
          "observed_at": "2017-09-11T13:39:27.000Z",
          "evidence": "https://web.archive.org/web/20170911133927/http://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Therapeutic Innovation: targeting neutrophil extracellular traps",
          "subhead": "Citryll, spun out from ModiQuest is taking a new approach to treat autoimmune diseases like Rheumatoid Arthritis (RA), Colitis and others by extinguishing the source of auto-antigens and neutrophil ex",
          "observed_at": "2018-08-11T08:45:50.000Z",
          "evidence": "https://web.archive.org/web/20180811084550/http://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeting the pathobiology of neutrophil extracellular traps",
          "subhead": "Citryll, is taking a new approach to treat autoimmune and other human diseases like lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis, by extinguishing the sou",
          "observed_at": "2019-07-21T11:15:20.000Z",
          "evidence": "https://web.archive.org/web/20190721111520/http://citryll.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Targeting the pathobiology of neutrophil extracellular traps",
      "subhead": "Citryll, is taking a new approach to treat autoimmune and other human diseases like lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis, by extinguishing the sou",
      "from": "2016-10-08T03:56:11.000Z",
      "to": "2019-07-21T11:15:20.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20190721111520/http://citryll.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2016-10-08T03:56:11.000Z",
          "to": "2019-07-21T11:15:20.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2024-07-18T22:40:39.000Z",
      "variants": [
        {
          "headline": "Citryll – Innovation in Medicine",
          "subhead": null,
          "observed_at": "2021-01-21T13:38:18.000Z",
          "evidence": "https://web.archive.org/web/20210121133818/https://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Citryll – Innovation in Medicine",
          "subhead": null,
          "observed_at": "2022-07-02T22:46:45.000Z",
          "evidence": "https://web.archive.org/web/20220702224645/https://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Citryll – Innovation in Medicine",
          "subhead": null,
          "observed_at": "2023-09-26T06:56:33.000Z",
          "evidence": "https://web.archive.org/web/20230926065633/https://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Citryll – Innovation in Medicine",
          "subhead": null,
          "observed_at": "2024-07-18T22:40:39.000Z",
          "evidence": "https://web.archive.org/web/20240718224039/https://citryll.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Citryll – Innovation in Medicine",
      "subhead": null,
      "from": "2021-01-21T13:38:18.000Z",
      "to": "2024-07-18T22:40:39.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20240718224039/https://citryll.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-01-21T13:38:18.000Z",
          "to": "2024-07-18T22:40:39.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-12-21T23:15:43.000Z",
      "variants": [
        {
          "headline": "Targeting the core of inflammatory disorders",
          "subhead": "Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.",
          "observed_at": "2025-06-18T23:11:19.000Z",
          "evidence": "https://web.archive.org/web/20250618231119/https://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeting the core of inflammatory disorders",
          "subhead": "Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.",
          "observed_at": "2025-12-21T23:15:43.000Z",
          "evidence": "https://web.archive.org/web/20251221231543/https://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeting the core of inflammatory disorders",
          "subhead": "Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.",
          "observed_at": "2025-12-21T23:15:43.000Z",
          "evidence": "https://web.archive.org/web/20251221231543/https://citryll.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Targeting the core of inflammatory disorders",
      "subhead": "Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.",
      "from": "2025-06-18T23:11:19.000Z",
      "to": "2025-12-21T23:15:43.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20251221231543/https://citryll.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2025-06-18T23:11:19.000Z",
          "to": "2025-12-21T23:15:43.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T12:40:54.279Z",
      "variants": [
        {
          "headline": "Resolving inflammation at its core",
          "subhead": "Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.",
          "observed_at": "2026-04-24T02:34:48.000Z",
          "evidence": "https://web.archive.org/web/20260424023448/https://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Resolving inflammation at its core",
          "subhead": "Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.",
          "observed_at": "2026-08-26T03:16:12.000Z",
          "evidence": "https://web.archive.org/web/20260826031612/https://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Resolving inflammation at its core",
          "subhead": "Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.",
          "observed_at": "2026-08-26T03:16:12.000Z",
          "evidence": "https://web.archive.org/web/20260826031612/https://citryll.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Resolving inflammation at its core",
          "subhead": "Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.",
          "observed_at": "2026-11-05T12:40:54.279Z",
          "evidence": "https://citryll.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Resolving inflammation at its core",
      "subhead": "Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.",
      "from": "2026-04-24T02:34:48.000Z",
      "to": "2026-11-05T12:40:54.279Z",
      "captures": 4,
      "evidence": "https://citryll.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-04-24T02:34:48.000Z",
          "to": "2026-11-05T12:40:54.279Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-ce593da93d756cddd1a0c6bbb10bdba60c6c55ab12036a3b15ec158c864e423a:8b5144e687581c1322418d83a04209425901bb2f83078825d46b7ce2a9d3877b:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20190721111520/http://citryll.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2019-07-21T11:15:20.000Z",
        "to": "2021-01-21T13:38:18.000Z"
      },
      "evidence": "https://web.archive.org/web/20210121133818/https://citryll.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 2,
      "id": "page-d5f4114b56d80efc4deb92eb61779e04cc5a89fc991d912cc80fb4e668dcee53:fd82ebbed13c0176097f1c796777bc5ee43fe972c8f7f2e1cf455c94e36714d0:headline:b1cf5d81683768fd",
      "before_evidence": "https://web.archive.org/web/20251221231543/https://citryll.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Targeting the core of inflammatory disorders” to “Resolving inflammation at its core”.",
      "between": {
        "from": "2025-12-21T23:15:43.000Z",
        "to": "2026-04-24T02:34:48.000Z"
      },
      "evidence": "https://web.archive.org/web/20260424023448/https://citryll.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": {
    "headline": "Citryll updates inflammation-focused homepage headline",
    "summary": "Citryll has changed its homepage headline wording while keeping an inflammation-related theme and previously added a careers page.",
    "points": [
      {
        "text": "Between December 2025 and April 2026, Citryll changed its homepage headline from “Targeting the core of inflammatory disorders” to “Resolving inflammation at its core”.",
        "kind": "fact",
        "changes": [
          2
        ]
      },
      {
        "text": "Between July 2019 and January 2021, Citryll added a careers page.",
        "kind": "fact",
        "changes": [
          1
        ]
      },
      {
        "text": "The shift in homepage wording between December 2025 and April 2026 suggests a refinement in how Citryll presents its inflammation-related focus rather than a change in topic.",
        "kind": "interpretation",
        "changes": [
          2
        ]
      }
    ],
    "written_at": "2026-11-07T16:08:40.453Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Citryll” company record, https://startuphistory.org/c/citryll.com"
}